Glut1 Glucose Transporter Activity in Human Brain Injury
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The principal glucose transporter at the blood-brain barrier (BBB) is the Glut1 isoform, and transporter density is believed to be an index of cerebral metabolic rate. In the present study, glucose transporter expression was studied in tissue resected 7-8 h after acute traumatic brain injuries in 2 patients. Light microscopic immunochemistry indicated a zone of complete loss of the Glut1 glucose transporter isoform in microvessel endothelial cells adjacent to sites of small vessel injury, concentrically surrounded by a narrow zone of variable Glut1, and distally surrounded by capillaries with typically immunoreactive endothelia in nondisrupted parenchyma. Variably reactive capillaries displayed alternating sectors of greatly reduced and highly reactive Glut1 density, suggesting a high density and low density of transporter activity in contiguous endothelial cells. Quantitative electron microscopic immunogold analyses demonstrated that the transporter was predominantly localized to the luminal and abluminal endothelial membranes, with lesser reactivity in cytoplasm; pericyte Glut1 was minimally above background levels. In endothelial sectors with reduced Glut1 transporter immunoreactivity, the luminal:abluminal ratio of Glut1 epitòpes was less than unity; while it is greater than unity in highly reactive endothelial cells. The number of Glut1-immunoreactive sites per micrometer of capillary membrane was not significantly different from previous reported Glut1 density in seizure resections, and about 2- to 3-fold higher than in human red cells. In the same tissue samples, qualitative immunogold electron microscopy of human serum albumin indicated leakage of this protein (MW 65,000) from the vascular space into pericapillary regions. Thus the high Glut1 density observed in capillaries from acutely injured brain occurs concomitantly with compromised barrier function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Farrell, C. L., & Pardridge, W. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5779 · Cited by 314 · cited 4×
“The immunoreactivity of the antiserum was confirmed in both Western blot analyses of isolated brain capillaries, and immunocyto-chemical procedures; absorption of the antiserum with the hGT eliminated antiserum reactivity with brain microvessels (Farrell and Pardridge, 1991).”
InfluentialHorwood, N., & Davies, D. C. (1994) · Virchows Archiv · doi:10.1007/bf00193951 · Cited by 97
Cited by
Glucose transporters in brain in health and disease
Koepsell, H. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02441-x · Cited by 558
“Immunoreactivity of an antibody against the human erythroid 55 kDa GLUT1 transporter was investigated by light and electron microscopy in brain cortex that had been resected from patients about 8 h after brain trauma [76].”
MethodPardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 447
Drug and gene targeting to the brain with molecular trojan horses
Pardridge, W. M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd725 · Cited by 439
The pathophysiology of traumatic brain injury at a glance
Prins, M., Greco, T., Alexander, D., & Giza, C. C. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011585 · Cited by 426
Oddo, M., Schmidt, J. M., Carrera, E., Badjatia, N., Connolly, E. S., Presciutti, M., Ostapkovich, N. D., Levine, J. M., Roux, P. L., & Mayer, S. A. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818f4026 · Cited by 419
Metadata
- Authors
- CORNFORD, E. M., HYMAN, S., CORNFORD, M. E., & CARON, M. J.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 1996-09
- Volume
- 13
- Issue
- 9
- Pages
- 523-536
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W1970392661
- Cited by
- 68
- References
- 2
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.